The design of proteins with improved or novel functions is an important goal with a variety of medical, industrial, environmental, and basic research applications. Now that combinatorial antibody libraries have been secured,, a powerful next step is the evolution toward artificial constructs as well as other protein motifs in which dimeric species are native or might be functional. Recently, we developed a phage-display format for the construction of highly diverse heterodimeric polypeptide arrays. With this approach, pVIII and pIX are utilized for the display of fusion proteins that form dimeric species. It is important to note that this is an entirely new methodology because one independently display protein motifs in close proximity to generate a library of functional interactions. The main goal of this proposal is to explore the potential of this approach for protein design. Inherent in the scope and power of the technology is the ability to display a variety of proteins that can engage in dimeric interactions. These include not only antibodies, but also some enzymes, hormones and hormone receptors, and DNA binding proteins. First, experiments have been designed to incorporate either combinatorial alteration of antibody framework regions and in other studies to reorganize and miniaturize the antibody chain for the creation of dimeric artificial amidases. Finally, we will display the phage 434 repressor protein as a library of heterodimers for selection against particular DNA sequences of clinical therapeutic importance. Our investigations represent a first step toward artificial antibodies and other protein motifs that will increase the understanding of protein- protein interactions and facilitate the selection of novel biological activities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA027489-21
Application #
6300205
Study Section
Project Start
2000-03-07
Project End
2001-02-28
Budget Start
Budget End
Support Year
21
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Zhu, Xueyong; Tanaka, Fujie; Lerner, Richard A et al. (2009) Direct observation of an enamine intermediate in amine catalysis. J Am Chem Soc 131:18206-7
Kamikubo, Yuichi; Kroon, Gerard; Curriden, Scott A et al. (2006) The reduced, denatured somatomedin B domain of vitronectin refolds into a stable, biologically active molecule. Biochemistry 45:3297-306
Zhu, Xueyong; Wentworth Jr, Paul; Kyle, Robert A et al. (2006) Cofactor-containing antibodies: crystal structure of the original yellow antibody. Proc Natl Acad Sci U S A 103:3581-5
Steiner, Derek D; Mase, Nobuyuki; Barbas 3rd, Carlos F (2005) Direct asymmetric alpha-fluorination of aldehydes. Angew Chem Int Ed Engl 44:3706-10
Suri, Jeff T; Ramachary, Dhevalapally B; Barbas 3rd, Carlos F (2005) Mimicking dihydroxy acetone phosphate-utilizing aldolases through organocatalysis: a facile route to carbohydrates and aminosugars. Org Lett 7:1383-5
Chowdari, Naidu S; Barbas 3rd, Carlos F (2005) Total synthesis of LFA-1 antagonist BIRT-377 via organocatalytic asymmetric construction of a quaternary stereocenter. Org Lett 7:867-70
Ramachary, Dhevalapally B; Barbas 3rd, Carlos F (2005) Direct amino acid-catalyzed asymmetric desymmetrization of meso-compounds: tandem aminoxylation/O-N bond heterolysis reactions. Org Lett 7:1577-80
Suri, Jeff T; Steiner, Derek D; Barbas 3rd, Carlos F (2005) Organocatalytic enantioselective synthesis of metabotropic glutamate receptor ligands. Org Lett 7:3885-8
Tanaka, Fujie; Fuller, Roberta; Barbas 3rd, Carlos F (2005) Development of small designer aldolase enzymes: catalytic activity, folding, and substrate specificity. Biochemistry 44:7583-92
Mase, Nobuyuki; Thayumanavan, Rajeswari; Tanaka, Fujie et al. (2004) Direct asymmetric organocatalytic Michael reactions of alpha,alpha-disubstituted aldehydes with beta-nitrostyrenes for the synthesis of quaternary carbon-containing products. Org Lett 6:2527-30

Showing the most recent 10 out of 155 publications